SOX17 and cervical cancer: This is the first study identified the SOX17 inhibited the proliferation and tumor formation by arresting the cells at cell cycle transition from G0/G1 phase to S phase in cervical cancer, in consistence with the results of another study in human oligodendroglioma49.